PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 59 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,084,000 | -73.1% | 3,889,900 | -24.4% | 1.42% | -72.7% |
| Q4 2015 | $15,178,000 | -20.0% | 5,144,916 | -14.3% | 5.23% | +6.0% |
| Q3 2015 | $18,974,000 | +156.4% | 6,004,564 | +380.3% | 4.93% | +142.1% |
| Q2 2015 | $7,401,000 | -50.4% | 1,250,167 | -10.4% | 2.04% | -64.4% |
| Q1 2015 | $14,914,000 | +40.0% | 1,395,167 | +23.0% | 5.72% | -20.7% |
| Q4 2014 | $10,654,000 | – | 1,134,578 | – | 7.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,134,578 | $10,654,000 | 7.22% |
| Consonance Capital Management LP | 3,427,789 | $32,187,000 | 4.15% |
| ACUTA CAPITAL PARTNERS, LLC | 604,075 | $5,672,000 | 3.83% |
| KOPP INVESTMENT ADVISORS LLC | 758,233 | $7,119,000 | 3.42% |
| Aisling Capital LLC | 2,010,000 | $18,874,000 | 2.86% |
| Broadfin Capital, LLC | 6,100,000 | $57,280,000 | 2.49% |
| THOMPSON DAVIS & CO., INC. | 154,760 | $1,453,000 | 1.68% |
| RUDMAN ERROL M | 300,000 | $2,817,000 | 1.14% |
| WALL STREET ASSOCIATES | 1,259,500 | $11,827,000 | 1.13% |
| Timpani Capital Management LLC | 291,377 | $2,736,000 | 1.08% |